Helus Pharma Inc. (HELP) stock

HELPNasdaqPharmaceutical PreparationsFiscal year ends March 31

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 40-F on Jun 29, 2026Score 0/30

$8.86−0.53 (-5.64%)

Close on Nov 12, 2026Market cap $457.46MP/E –Yield –

Helus Pharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Helus Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?